Zhitong Finance App News, Changchun Hi-Tech (000661.SZ) issued an announcement. According to the relevant rules of the US Food and Drug Administration (“FDA”), the company's subsidiary, Changchun Jinsai Pharmaceutical Co., Ltd. (hereinafter referred to as “Jinsai Pharmaceutical”), has obtained implied approval from the FDA to apply for clinical trials of new drugs.

Zhitongcaijing · 10/14 12:25
Zhitong Finance App News, Changchun Hi-Tech (000661.SZ) issued an announcement. According to the relevant rules of the US Food and Drug Administration (“FDA”), the company's subsidiary, Changchun Jinsai Pharmaceutical Co., Ltd. (hereinafter referred to as “Jinsai Pharmaceutical”), has obtained implied approval from the FDA to apply for clinical trials of new drugs.